Suanfarma Suanfarma

X

CAS 135821-54-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 135821-54-4
Also known as: Ceftizoxime alapivoxil, 135821-54-4, Ceftizoxime alapivoxil [inn], 3mm3320ljn, As-924, Unii-3mm3320ljn
Molecular Formula
C22H28N6O8S2
Molecular Weight
568.6  g/mol
InChI Key
VOPANQNVVCPHQR-IVVGYLHBSA-N
FDA UNII
3MM3320LJN

Ceftizoxime Alapivoxil is the alapivalate ester prodrug form of ceftizoxime, a semi-synthetic, broad-spectrum, beta-lactamase-resistant, third-generation cephalosporin with antibacterial activity. After oral administration of ceftizoxime alapivoxil, the ester bond is cleaved, releasing active ceftizoxime.
1 2D Structure

CAS 135821-54-4

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-[2-[[(2S)-2-aminopropanoyl]amino]-1,3-thiazol-4-yl]-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2.1.2 InChI
InChI=1S/C22H28N6O8S2/c1-10(23)15(29)26-21-24-11(8-38-21)13(27-34-5)16(30)25-14-17(31)28-12(6-7-37-18(14)28)19(32)35-9-36-20(33)22(2,3)4/h6,8,10,14,18H,7,9,23H2,1-5H3,(H,25,30)(H,24,26,29)/b27-13-/t10-,14+,18+/m0/s1
2.1.3 InChI Key
VOPANQNVVCPHQR-IVVGYLHBSA-N
2.1.4 Canonical SMILES
CC(C(=O)NC1=NC(=CS1)C(=NOC)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)OCOC(=O)C(C)(C)C)N
2.1.5 Isomeric SMILES
C[C@@H](C(=O)NC1=NC(=CS1)/C(=N/OC)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)OCOC(=O)C(C)(C)C)N
2.2 Other Identifiers
2.2.1 UNII
3MM3320LJN
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2-(2-alanylaminothiazol-4-yl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylate

2. As 924

3. As-924

4. Ceftizoxime Alapivoxil

2.3.2 Depositor-Supplied Synonyms

1. Ceftizoxime Alapivoxil

2. 135821-54-4

3. Ceftizoxime Alapivoxil [inn]

4. 3mm3320ljn

5. As-924

6. Unii-3mm3320ljn

7. Chembl2106058

8. Zinc59660352

9. C21592

10. (2-(2-alanylaminothiazol-4-yl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylate

11. (+)-(pivaloyloxy)methyl (6r,7r)-7-(2-(2-(l-alanylamino)thiazol-4-yl)glyoxylamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(z)-(o)-methyloxime)

12. (+)-(pivaloyloxy)methyl (6r,7r)-7-(2-(2-(l-alanylamino)thiazol-4-yl)glyoxylamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7,2-(z)-(o)-methyloxime)

13. (+)-(pivaloyloxy)methyl (6r,7r)-7-(2-(2-(l-alanylamino)thiazol-4-yl)glyoxylamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 72-(z)-(o)-methyloxime)

14. (7r)-7-[2-[2-[[(2s)-2-aminopropionyl]amino]thiazole-4-yl]-2-(methoxyimino)acetylamino]cepham-3-ene-4-carboxylic Acid (pivaloyloxy)methyl Ester

2.4 Create Date
2006-10-24
3 Chemical and Physical Properties
Molecular Weight 568.6 g/mol
Molecular Formula C22H28N6O8S2
XLogP31.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count13
Rotatable Bond Count12
Exact Mass568.14100422 g/mol
Monoisotopic Mass568.14100422 g/mol
Topological Polar Surface Area245 Ų
Heavy Atom Count38
Formal Charge0
Complexity1050
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
117467-28-4
Cephalosporin
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in...
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Development Zone, is a key intermediate cephalosporin antibiotics, APIs, DDP-4 hypoglycemic agents , Development, production and sales of specialized pharmaceutical companies. In 2016 the company obtained the national high-tech enterprise certification. Company under the Hubei Ling Sheng Pharmaceutical Co., Ltd. Wuhan Branch. The company has the core technology, is currently the industry's major oral cephalosporin antibiotics API production base.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
87239-81-4
Cephalosporin
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in...
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Development Zone, is a key intermediate cephalosporin antibiotics, APIs, DDP-4 hypoglycemic agents , Development, production and sales of specialized pharmaceutical companies. In 2016 the company obtained the national high-tech enterprise certification. Company under the Hubei Ling Sheng Pharmaceutical Co., Ltd. Wuhan Branch. The company has the core technology, is currently the industry's major oral cephalosporin antibiotics API production base.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
104146-10-3
Cephalosporin
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in...
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Development Zone, is a key intermediate cephalosporin antibiotics, APIs, DDP-4 hypoglycemic agents , Development, production and sales of specialized pharmaceutical companies. In 2016 the company obtained the national high-tech enterprise certification. Company under the Hubei Ling Sheng Pharmaceutical Co., Ltd. Wuhan Branch. The company has the core technology, is currently the industry's major oral cephalosporin antibiotics API production base.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
147816-24-8
Cephalosporin
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in...
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Development Zone, is a key intermediate cephalosporin antibiotics, APIs, DDP-4 hypoglycemic agents , Development, production and sales of specialized pharmaceutical companies. In 2016 the company obtained the national high-tech enterprise certification. Company under the Hubei Ling Sheng Pharmaceutical Co., Ltd. Wuhan Branch. The company has the core technology, is currently the industry's major oral cephalosporin antibiotics API production base.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
97519-39-6
Cephalosporin
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in...
Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Development Zone, is a key intermediate cephalosporin antibiotics, APIs, DDP-4 hypoglycemic agents , Development, production and sales of specialized pharmaceutical companies. In 2016 the company obtained the national high-tech enterprise certification. Company under the Hubei Ling Sheng Pharmaceutical Co., Ltd. Wuhan Branch. The company has the core technology, is currently the industry's major oral cephalosporin antibiotics API production base.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
957-68-6
Cephalosporin
Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shangha...
Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shanghai is only 1.5 hours by car. Established in 2006, we have developed quickly into a comprehensive entity engaged in and marketing, developing and manufacturing of Active Pharmaceutical Ingredients, intermediates and fine chemicals.Our collaboration production site is in the national chemical park in our city: Nantong Rudong Yangkou Chemical park. Available test instrument in the production site: IR, UV, HPLC, GC, etc.. Production equipment: More than 50 reactors, size from 1L to 3000L , reaction temperature from -10℃ to +300℃.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
54639-48-4
Cephalosporin
Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square mete...
Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square meters, is a high-tech shareholding company with a total investment of one hundred millionyuan. As an influential producer of cholic products both in China and abroad, our company specializes in researching, developing, manufacturing and marketing biological APIs and pharmaceutical intermediates. At present, we have 10 invention patents and establish a technology research center of cholic products that undertakesmultiple national projects.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
79349-82-9
Cephalosporin
Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square mete...
Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square meters, is a high-tech shareholding company with a total investment of one hundred millionyuan. As an influential producer of cholic products both in China and abroad, our company specializes in researching, developing, manufacturing and marketing biological APIs and pharmaceutical intermediates. At present, we have 10 invention patents and establish a technology research center of cholic products that undertakesmultiple national projects.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
36923-17-8
Cephalosporin
Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square mete...
Suzhou Tianlu Bio-pharmaceutical Co.,Ltd., established in Dec.1999 covering an area of 26,666 square meters, is a high-tech shareholding company with a total investment of one hundred millionyuan. As an influential producer of cholic products both in China and abroad, our company specializes in researching, developing, manufacturing and marketing biological APIs and pharmaceutical intermediates. At present, we have 10 invention patents and establish a technology research center of cholic products that undertakesmultiple national projects.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY